Quick Answer
RELMADA THERAPEUTICS, INC. reported Total Assets of $94.00 million for the year ending 2025.
- RELMADA THERAPEUTICS, INC. showed an increase of +105.2% in Total Assets from 2024 to 2025.
- This data is from RELMADA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $10.2 thousand | Q2 2013: $4.7 thousand | Q3 2013: $20.0 thousand | Q4 2013: $12.3 thousand | Q1 2014: $10.0 thousand | Q3 2014: $27.85 million | Q4 2014: $32.79 million | Q1 2015: $27.85 million | Q2 2015: $24.39 million | Q3 2015: $20.48 million | Q4 2015: $16.60 million | Q1 2016: $12.72 million | Q3 2016: $7.92 million | Q4 2016: $6.23 million | Q1 2017: $4.17 million | Q3 2017: $5.61 million | Q4 2017: $6.57 million | Q1 2018: $4.80 million | Q3 2018: $1.56 million | Q4 2018: $3.30 million | Q1 2019: $2.60 million | Q3 2019: $8.51 million | Q1 2020: $115.42 million | Q2 2020: $134.56 million | Q3 2020: $125.60 million | Q1 2021: $103.87 million | Q2 2021: $110.77 million | Q3 2021: $90.93 million | Q1 2022: $225.81 million | Q2 2022: $215.77 million | Q3 2022: $187.12 million | Q1 2023: $135.57 million | Q2 2023: $122.04 million | Q3 2023: $109.15 million | Q1 2024: $84.41 million | Q2 2024: $71.03 million | Q3 2024: $55.72 million | Q1 2025: $27.68 million | Q2 2025: $21.12 million | Q3 2025: $14.88 million.
- Over the full 15 years of available data (2012 to 2025), RELMADA THERAPEUTICS, INC.'s Total Assets has grown by 512,068.9%.
- Historical annual values: Fiscal year 2025: $94.00 million | Fiscal year 2024: $45.82 million | Fiscal year 2023: $97.55 million | Fiscal year 2022: $152.91 million | Fiscal year 2021: $223.33 million | Fiscal year 2020: $118.19 million | Fiscal year 2019: $117.14 million | Fiscal year 2019: $10.22 million | Fiscal year 2018: $3.05 million | Fiscal year 2017: $2.84 million | Fiscal year 2016: $10.24 million | Fiscal year 2015: $24.39 million | Fiscal year 2014: $25.76 million | Fiscal year 2013: $20.0 thousand | Fiscal year 2012: $18.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: